FCF Biotech Venture Capital Monitor – USA 11/2020 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 11/2020”.

The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector.

As of the end of November 2020, we identify the following current VC trends in the US-Biotech sector:

  • In November 2020 the investment volume in the US-Biotech sector amounted to USD 1,655m
  • In 2020, overall Biotech funding in the USA has reached USD 20,570m so far
  • Top 5 deals exceed USD 300m each, largest transaction amounted to USD 493m in Lyell Immunopharma, Inc.

To access the full report, please click here.

By Dr. Mathias Schott, Sebastian Sommer and Alexander Kuhn